| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 16, 2018Virtual Press Office and PR Newswire: General Trade show news
Forty Seven, Inc., a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced that, Data from its ongoing Phase...
-
May 16, 2018Virtual Press Office and PR Newswire: General Trade show news
Eli Lilly and Company (NYSE: LLY) today announced that new results from a number of studies across the company's oncology product and pipeline portfolio will be presented at the 54th Annual...
-
May 16, 2018Virtual Press Office and PR Newswire: General Trade show news
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the first positive Phase 1 clinical data assessing cemiplimab as a potential treatment for advanced non-small cell...
-
May 16, 2018Virtual Press Office and PR Newswire: General Trade show news
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that a wide selection of abstracts highlighting the Company's diverse oncology portfolio...
-
May 16, 2018Virtual Press Office and PR Newswire: General Trade show news
MEI Pharma, Inc. (NASDAQ: MEIP), a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer, today announced...
